Global Artificial Heart Lung Machines Market Insights, Forecast to 2025
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
The classification of artificial heart lung machines includes single roller pump HLM and double roller pump HLM, and the revenue proportion of single roller pump HLM in 2016 is about 66.3%. Artificial heart lung machines can be used for cardiac surgery, lung transplant operation, acute respiratory failure treatment and other. The most proportion of artificial heart lung machines is used for cardiac surgery, and the sales proportion is about 66.2% in 2016.
North America is the largest sales place, with a sales market share nearly 36.4% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 33.3%. China, Japan and Korea are also important sales regions for artificial heart lung machines.
Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59.6% of revenue share in 2016. MAQUET followed as second produced about 18.3% in 2016.
The global Artificial Heart Lung Machines market is valued at 250 million US$ in 2018 and will reach 310 million US$ by the end of 2025, growing at a CAGR of 2.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Artificial Heart Lung Machines market based on company, product type, end user and key regions.
This report studies the global market size of Artificial Heart Lung Machines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Artificial Heart Lung Machines in these regions.
This research report categorizes the global Artificial Heart Lung Machines market by top players/brands, region, type and end user. This report also studies the global Artificial Heart Lung Machines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Market size by Product
Single Roller Pump HLM
Double Roller Pump HLM
Market size by End User
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Artificial Heart Lung Machines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Artificial Heart Lung Machines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Artificial Heart Lung Machines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Artificial Heart Lung Machines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Artificial Heart Lung Machines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Artificial Heart Lung Machines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The classification of artificial heart lung machines includes single roller pump HLM and double roller pump HLM, and the revenue proportion of single roller pump HLM in 2016 is about 66.3%. Artificial heart lung machines can be used for cardiac surgery, lung transplant operation, acute respiratory failure treatment and other. The most proportion of artificial heart lung machines is used for cardiac surgery, and the sales proportion is about 66.2% in 2016.
North America is the largest sales place, with a sales market share nearly 36.4% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 33.3%. China, Japan and Korea are also important sales regions for artificial heart lung machines.
Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59.6% of revenue share in 2016. MAQUET followed as second produced about 18.3% in 2016.
The global Artificial Heart Lung Machines market is valued at 250 million US$ in 2018 and will reach 310 million US$ by the end of 2025, growing at a CAGR of 2.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Artificial Heart Lung Machines market based on company, product type, end user and key regions.
This report studies the global market size of Artificial Heart Lung Machines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Artificial Heart Lung Machines in these regions.
This research report categorizes the global Artificial Heart Lung Machines market by top players/brands, region, type and end user. This report also studies the global Artificial Heart Lung Machines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Market size by Product
Single Roller Pump HLM
Double Roller Pump HLM
Market size by End User
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Artificial Heart Lung Machines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Artificial Heart Lung Machines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Artificial Heart Lung Machines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Artificial Heart Lung Machines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Artificial Heart Lung Machines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Artificial Heart Lung Machines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
